A good clonal response to chemotherapy in AL amyloidosis is associated with improved quality of life and function at 1 year

Amyloid. 2017 Mar;24(sup1):72-73. doi: 10.1080/13506129.2017.1295944.
No abstract available

Publication types

  • Letter
  • Observational Study

MeSH terms

  • Antineoplastic Agents, Alkylating / therapeutic use*
  • Dyspnea / diagnosis
  • Dyspnea / physiopathology
  • Fatigue / diagnosis
  • Fatigue / physiopathology
  • Humans
  • Immunoglobulin Light-chain Amyloidosis / diagnosis*
  • Immunoglobulin Light-chain Amyloidosis / drug therapy
  • Immunoglobulin Light-chain Amyloidosis / physiopathology
  • Immunoglobulin Light-chain Amyloidosis / psychology
  • Melphalan / therapeutic use*
  • Pain / diagnosis
  • Pain / physiopathology
  • Prospective Studies
  • Quality of Life / psychology*
  • Sleep Initiation and Maintenance Disorders / diagnosis
  • Sleep Initiation and Maintenance Disorders / physiopathology
  • Treatment Outcome

Substances

  • Antineoplastic Agents, Alkylating
  • Melphalan